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The development of a membrane-bound structure separating DNA from other cellular components was the
epochal evolutionary event that gave rise to eukaryotes, possibly occurring up to 2 billion years ago. Yet, this
view of the nuclear envelope as a physical barrier greatly underestimates its fundamental impact on cellular
organization and complexity, much of which is only beginning to be understood. Indeed, alterations of
nuclear envelope structure and protein composition are essential tomany aspects of metazoan development
and cellular differentiation. Mutations in genes encoding nuclear envelope proteins cause a fascinating array
of diseases referred to as ‘‘nuclear envelopathies’’ or ‘‘laminopathies’’ that affect different tissues and organ
systems.We review recent work on the nuclear envelope, including insights derived from the study of nuclear
envelopathies. These studies are uncovering new functions for nuclear envelope proteins and underlie an
emerging view of the nuclear envelope as a critical signaling node in development and disease.Introduction
Despite the common cartoon image of the nucleus as a symmet-
rical sphere, a quick glance at a textbook of histology or the
results from a Google Image Search makes it obvious that there
is great diversity of nuclear shape and that striking differences
exist in the nuclear structure of metazoan cells. These differ-
ences exist both between cell types and within a single cell
type at different stages of differentiation. For example, there
are striking differences between the largely spherical neuronal
nucleus and the highly lobulated nucleus of the peripheral blood
neutrophil (Figure 1). Additionally, both of these cell types have
very differently shaped nuclei at earlier stages of differentiation:
migrating neurons have highly irregular and distorted-appearing
nuclei, whereas the myeloblastoid precursor of the neutrophil is
a regular spheroid (Figure 1). While these structural alterations in
nuclear shape have been known for decades, little is known
about the underlying mechanisms or the biological significance
of these events.
Similarly enigmatic are the compositional and consequent
functional differences that exist between the nuclear envelopes
of different cell types. The fact that tissue-specific disease
commonly results from mutations in genes encoding widely ex-
pressed nuclear envelope proteins is evidence of cell-type-
specific differences in nuclear envelope function. Most notable
are the tissue-specific diseases that result from mutations in
LMNA, the gene encoding the widely expressed A-type lamins.
LMNA mutations cause a range of clinical disorders that affect
different tissues and some (the progerias) that even affect the
aging process itself, highlighting the many crucial functions
localized to the nuclear envelope. The best-appreciated
nuclear-envelope-localized function is that of nucleocytoplasmic
transport, mediated by nuclear pore complexes. Yet, new626 Developmental Cell 17, November 17, 2009 ª2009 Elsevier Incstudies have identified novel functions of nuclear pore proteins
(nucleoporins), including roles in cell division, transcriptional
regulation, and signaling. Indeed, an emerging body of work
supports a new view of the nuclear envelope as a node that inte-
grates and transduces a range of signals during development
and in terminally differentiated cells. Hence, beyond its classical
barrier function, studies of the nuclear envelope are increasingly
providing insights into basic aspects of cellular organization and
function and providing novel insights into the pathogenesis of
human disease.
Nuclear Envelope Alterations in Development
and Differentiation
The striking diversity and plasticity of nuclear morphology
implies that there are mechanisms that control the shape and
protein composition of the nuclear envelope. Dissecting these
pathways would likely lead to the discovery of new mechanisms
that control development and differentiation and perhaps shed
light on the biological reasons for the marked changes in
nuclear morphology that are observed between cell types and
during cell differentiation. Moreover, given the frequent associ-
ation of nuclear shape changes with human disease—both with
the rare nuclear envelopathies (see below) as well as prevalent
diseases such as cancer—knowledge of these pathways should
be helpful in unraveling the potential pathogenic significance of
these morphological observations. This issue of Developmental
Cell contains detailed reviews of the nuclear pore complex and
the protein complexes that link the nucleoskeleton and cyto-
skeleton (the LINC complexes). In this Review, we therefore
focus our discussion on in vivo studies exploring the dynamic
changes known to occur at the nuclear envelope and loss-of-
function studies in worm, fly, and mouse that link nuclear.
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differentiation.
Nucleoporins
A varying requirement for nucleocytoplasmic transport makes it
intuitive that signaling pathways must exist that control the
number and composition of nuclear pores between different
cell types and at different stages of development. Early observa-
tional studies using electron microscopy documented differ-
ences in the number and density of nuclear pores between
different cell types. For example, there is a 5-fold increase in
neuronal nuclear pore number between the 18th prenatal and
15th postnatal days in mice, followed by a gradual decrease to
steady-state levels around the 180th postnatal day (Lodin
et al., 1978). Later observations in vitro linked the number of
nuclear pores to transcriptional or nucleocytoplasmic transport
activity (Maul et al., 1980). In cycling cells, the number of nuclear
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Figure 1. Differences in Nuclear Shape during Cellular
Differentiation and in Terminally Differentiated Cells
The developing cortical neuron (left) and the blood neutrophil (right) exhibit
differences in nuclear morphology. There are striking differences between
the largely spherical adult neuronal nucleus and the highly lobulated mature
neutrophil nucleus. Both of these cells also have very differently shaped nuclei
at earlier stages of differentiation: migrating neurons having irregular distorted-
appearing nuclei, whereas the precursors of the mature neutrophil have more
spheroidal nuclei. Diagrams of cortical neurons are based upon micrographs
in Goodchild et al. (2005).pore complexes also doubles during S phase in preparation for
mitosis. Some of the mechanisms underlying the dynamic
behavior of pore complexes are beginning to be uncovered in
a large body of work performed in yeast and cultured cell lines;
this work has identified specific nucleoporins that are critical
for nuclear pore assembly and maintenance and has demon-
strated the existence of distinct transport pathways (see Hetzer
and Wente, 2009).
Although many nucleoporins are nonessential in yeast (Fabre
and Hurt, 1997), the genetic deletion of most nucleoporins
causes early embryonic lethality in worms, flies, or mice, demon-
strating the critical role played by the nuclear pore complex
duringmetazoan development. Despite these early lethal pheno-
types, examination of the embryos, or cells derived from them,
has yielded interesting insights into the role of the pore complex
in basic cell biological processes. For example, RNA interference
(RNAi)-mediated knockdown of multiple nucleoporins in the
wormCaenorhabditis elegans all led to a similar defect in spindle
orientation at the two cell stage (Schetter et al., 2006), suggesting
that these proteins function in a common process, perhaps
related to the connection of the cytoskeleton to the nuclear
surface. Deletion of Nup98 in mice led to lethality at embryonic
day 6.5 to 7.5, and assessment of these embryos suggested
a role for these nucleoporins in gastrulation (Wu et al., 2001).
Interestingly, loss of Nup98 specifically impaired cytoplasmically
oriented nucleoporins and led to a selective defect in transport of
proteins with a nuclear localization signal (Wu et al., 2001). Dele-
tion of Nup96 also leads to early lethality in mice, but character-
ization of cells from Nup96+/ mice demonstrates a role for this
protein (and the Nup107-160 complex to which it belongs) in
the control of cell-cycle progression (Chakraborty et al., 2008).
Interestingly, Nup96+/ mice also show a defect in innate and
adaptive immunity, in part related to impaired T cell proliferation
(Faria et al., 2006), illustrating how a fundamental defect (prolifer-
ation) can cause a relatively tissue-specific phenotype, depend-
ing upon the tissue’s functional characteristics.
Cell-specific or developmental-stage-specific protein expres-
sion are additional mechanisms that can lead to tissue-specific
phenotypes. A number of studies have documented nuclear
pore proteins with such expression differences, most notably
in the developing nervous system. Genetic deletion of Nup133
or Nup50 in mice both cause lethality at approximately embry-
onic day 9.5 and a kinked neural tube that fails to close normally
(exencephaly), in addition to other abnormalities (Lupu et al.,
2008; Smitherman et al., 2000). Although both of these nucleo-
porins exhibit widespread expression in the embryo, the expres-
sion of both is markedly higher in the neural tube. Lupu et al.
(2008) also demonstrated defects in neuronal differentiation
in vivo and showed that embryonic stem cells from these mice
are selectively inefficient in neuronal differentiation, suggesting
a specific role for this nucleoporin in neuronal differentiation.
Differentiation-stage-dependent differences in expression of
karyopherin/importin-a have also been implicated in the
progression of neural differentiation (Yasuhara et al., 2007).
Nuclear Lamina
The nuclear lamina is a meshwork of intermediate filaments that
resides on the inner aspect of the inner nuclear membrane and is
composed of proteins called lamins (Gerace et al., 1978; AebiDevelopmental Cell 17, November 17, 2009 ª2009 Elsevier Inc. 627
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Figure 2. Nuclear Envelope and Nuclear
Lamina
The nuclear envelope surrounds the nucleus and is
composed the nuclear membranes, nuclear pore
complexes, and nuclear lamina. The inner and
outer nuclear membranes are separated by the
perinuclear space, a continuation of the endo-
plasmic reticulum lumen. As a result, proteins
secreted into the endoplasmic reticulum, such as
torsinA (TOR1A), can potentially reach the perinu-
clear space; a disease-causing torsinA variant
preferentially accumulates in the perinuclear
space by binding to lamina-associated protein-1.
Some proteins, such as large nesprin-2 isoforms,
concentrate in the outer nuclear membrane by
binding to SUN proteins within the perinuclear
space. The nuclear lamina is a meshwork of inter-
mediate filaments on the inner aspect of the inner
nuclear membrane and is composed of proteins
called lamins. The lamina is associated with inte-
gral proteins of the inner nuclear membrane and
representative examples—MAN1, lamina-associ-
ated polypeptide-1 (LAP1), the SUN protein
lamina-associated polypeptide-2b (LAP2 2b),
lamin B receptor (LBR), emerin, and a nesprin-1
isoform—are shown. The general structure of
a lamin molecule is shown in the lower inset (not
to scale). Lamins have a-helical rod domains that
are highly conserved among all intermediate fila-
ment proteins and are critical for the formation of
dimers and higher-ordered filaments. They have
head and tail domains that vary in sequence
among members of intermediate filament protein
family. Within the tail domain, lamins contain
a nuclear localization signal (NLS) and an immuno-
globulin-like fold (Ig fold). Most lamins (not
mammalian lamin C or C2) contain at their
carboxyl-termini a CAAXmotif that acts as a signal
to trigger a series of chemical reactions leading to
protein modification by fanesylation and carboxy-
methylation.et al., 1986; Goldman et al., 1986) (Figure 2). Though absent from
lower eukaryotes such as yeast, the lamina is present in all nucle-
ated cells of higher organisms (Fawcett, 1966; Cohen and
Sundeen, 1976; Gerace et al., 1978). Lamins have a-helical
central rod domains that are highly conserved among all inter-
mediate filament proteins and head and tail domains that vary
in sequence among members of the intermediate filament
protein family (Fisher et al., 1986; McKeon et al., 1986). The
rod domains are critical for the formation of the dimers and para-
crystalline arrays in vitro (Heitlinger et al., 1992). Within the tail
domains, lamins contain nuclear localization signals (Fisher
et al., 1986; McKeon et al., 1986) and an immunoglobulin-like
fold (Dhe-Paganon et al., 2002; Krimm et al., 2002). All the
mammalian lamins except for lamin C and lamin C2 contain
CAAX motifs at their carboxyl-termini, a signal for farnesylation.
In mammals, three genes encode lamins. The A-type lamins,
lamin A and lamin C, arise by alternative RNA splicing from
LMNA. They share the same first 566 amino acids and differ in
their carboxyl-terminal ends. The somatic cell B-type lamins
are lamin B1, encoded by LMNB1, and lamin B2, encoded by
LMNB2. Germ-cell-specific isoforms lamin B3 and lamin C2
arise from alternative splicing of transcripts encoded respec-
tively by LMNB1 and LMNA.
Lamin A is synthesized as a precursor called prelamin A. The
CAAX motif of prelamin A directs it to become farnesylated on628 Developmental Cell 17, November 17, 2009 ª2009 Elsevier Inc.its C-terminal cysteine; the -AAX is then cleaved off by
ZMPSTE24, an endoprotease. The carboxyl-terminal cysteine
is subsequently carboxymethylated and the farnesylated, car-
boxymethylated protein is again recognized by ZMPSTE4, which
cleaves prelamin A at 15 amino acids ‘‘upstream’’ of the farnesy-
lated cysteine to yield mature lamin A. Only prelamin A
undergoes this type of processing; B-type lamins remain farne-
sylated and carboxymethylated. It remains unclear why B-type
lamins are farnesylated but at least one consequence of farnesy-
lation is an enhanced membrane association, either directly or
via protein-protein interactions. It is less clear why prelamin A
undergoes farnesylation and processing that ultimately leads
to removal of the farnesyl group. However, abnormalities in prel-
amin A processing have detrimental effects that lead to serious
disease (discussed below).
Early studies showed that the nuclear lamina of rat liver nuclei
contained roughly equivalent amounts of lamin A, ‘‘lamin B’’
(probablymostly lamin B1 and some lamin B2), and lamin C (Ger-
ace et al., 1978). However, observations of differences in lamina
‘‘thickness’’ between various human cell types (Cohen and
Sundeen, 1976) indicated that the lamina is not an invariant
structure and suggested that differences in protein expression
levels and/or stoichiometry may underlie this morphological
diversity. In 1987, it was shown that only ‘‘lamin B’’ was present
in the lamina of some undifferentiated cell types and that A-type
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and Burke, 1987). Although a comprehensive analysis of multiple
cell types and tissues is lacking, data from many different pub-
lished observations indicate that the different A-type and
B-type lamins can be expressed at various stoichiometries
in different cells and tissues at various stages of cellular differen-
tiation.
Loss-of-function studies of lamins in model organisms have
generally resulted in more profound phenotypes in invertebrates
than in mice, likely reflecting the fact that these organisms have
fewer lamin isoforms (C. elegans has only one) and suggesting
a degree of functional overlap between isoforms. Deletion of
lmn-1, the only C. elegans lamin gene, causes early lethality
with marked nuclear disorganization, including abnormalities in
chromatin organization and chromosome segregation during
mitosis (Liu et al., 2000). Deletion of the lamin C homolog in the
fly Drosophila melanogaster causes a similar, although some-
what less dramatic, early lethal phenotype at the prepupal stage
(Schulze et al., 2005). However, loss of Dm(0), which encodes
a B-type lamin in Drosophila, yields more complex phenotypes.
Some Dm(0) null flies survive into adulthood, though most die
much earlier (Guillemin et al., 2001; Lenz-Bo¨hme et al., 1997;
Osouda et al., 2005). Developmental retardation appears to be
particularly marked in the central nervous system (CNS) and
ovaries, whereas other tissue, such as the ventriculus, is hyper-
trophic yet normally organized (Osouda et al., 2005). Thus, the
Dm(0) function does not simply disrupt cell function but may
play more specific roles in the differentiation of certain tissues.
Similar observations have been made in the development of
the tracheal system in Dm(0) mutants (Guillemin et al., 2001).
In contrast to findings in invertebrates, mice lacking A-type
lamins have apparently normal embryonic development, appear-
ing grossly normal at birth (Sullivan et al., 1999). The postnatal
growth of these mice is retarded, however, and they develop
abnormalities of cardiac and skeletal muscle. These phenotypes
in A-type lamin-deficient mice may result primarily from the loss
of lamin C, as mice that selectively lack lamin A appear normal
into adulthood (Fong et al., 2006b). Lamin B1 null mice die during
early postnatal life and exhibit relatively tissue-specific abnor-
malities of lung and bone (Vergnes et al., 2004). Interestingly,
the bone abnormalities include abnormal overgrowth of cranial
structures, a hypertrophic phenotype reminiscent of that seen
in Drosophila Dm(0) mutants (Osouda et al., 2005).
Nuclear Membrane Proteins
The inner nuclear membrane contains a unique set of transmem-
brane proteins, many of which interact with the lamina and/or
chromatin proteins. Biochemical data from rat liver suggest that
approximately 70 transmembrane proteins are relatively concen-
trated at the inner nuclear membrane (Schirmer et al., 2003).
Although there are less systematic data currently available, vari-
able expressionof integral inner nuclearmembraneproteins likely
occurs between differentiated tissues and during cellular differ-
entiation. Genetic deletions in model organisms suggest that
proper expression of several integral inner nuclear membrane
proteins is essential for normal development. Most studied is
MAN1, for which evidence from mice, flies, and frogs support
in vitro experiments implicating this protein in transforming
growth factor-b signaling. This is consistent with disease pheno-types of patients with mutations in LEMD3 encoding MAN1 (see
below). MAN1-deficient mice die during embryogenesis as
a result of abnormal yolk-sac vascularization (Ishimura et al.,
2006; Cohen et al., 2007) and exhibit abnormal heartmorphogen-
esis resulting fromaberrant expressionof left-side-specificgenes
responsible for left-right asymmetry (Ishimura et al., 2008). Both
of these defects have been linked to enhanced transforming
growth factor-b signaling. Similarly, tissue-specific defects
resulting from deletion of theMAN1 homolog inDrosophila (Pinto
et al., 2008) and abnormalities caused by overexpression or
knockdown of the Xenopus MAN1 homolog in embryos (Osada
et al., 2003; Raju et al., 2003) appear to result from alterations in
signaling by transforming growth factor-b family members.
Spontaneous mutations at the mouse ichthyosis locus, shown
by Shultz et al. (2003) to lead to loss of expression of the inner
nuclear membrane protein lamin B receptor, lead to hair and
skin abnormalities as well as clumping of heterochromatin in
the nuclei of neutrophils, lymphocytes, and other cells. Mice
with a gene trap insertion into the Lbr locus have a similar pheno-
type, and both lines of LBR-deficient mice demonstrate that this
protein is essential for the morphological maturation of neutro-
phils (Cohen et al., 2008). This is consistent with the observation
that heterozygous mutations in human LBR cause the Pelger-
Hue¨t anomaly (see below). Mice with deletions of the X chromo-
some gene encoding emerin, another integral protein of the inner
nuclear membrane, are fertile and have normal lifespans with
only very subtle abnormalities of striated muscle (Melcon et al.,
2006; Ozawa et al., 2006), although loss of emerin in humans
causes significant cardiac and skeletal muscle disease (see
below). Deletions of genes encoding the inner nuclear
membrane SUN proteins, which bind to nesprins in the outer
nuclear membrane as part of the nucleo-cytoskeletal LINC
complex, result in defects mostly involving proper nuclear posi-
tioning and cell migration (reviewed by Burke and Roux, 2009).
Positional Cloning Brings a New Perspective
to the Nuclear Envelope
Following the discovery by positional cloning that mutations in
the EDM gene cause X-linked Emery-Dreifuss muscular
dystrophy (Bione et al., 1994), it came as a surprise when its
gene product, emerin, was localized to the nuclear envelope
(Manilal et al., 1996; Nagano et al., 1996). Even more surprising
was the identification by Bonne et al. (1999), using positional
cloning, that mutations in LMNA, the gene that encodes the
long-studied A-type lamins, cause autosomal dominant Emery-
Dreifuss muscular dystrophy (a phenocopy of the X-linked
form). Hence, in contrast to the severe, potentially lethal pheno-
types most cell biologists might have suspected, defects in
widely expressed nuclear envelope proteins were shown to
have tissue-selective effects that do not manifest until well after
birth, in some cases only appearing during adulthood. These
discoveries challenged existing concepts of nuclear envelope
function and have led to new insights into the function of this
organelle, especially with regard to development and disease.
It is now clear that several Mendelian diseases result from muta-
tions in genes encoding widely-expressed components of the
nuclear lamina, nuclear membranes, and nuclear pore
complexes and that many of these manifest as tissue-selective
disorders (Table 1).Developmental Cell 17, November 17, 2009 ª2009 Elsevier Inc. 629
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Nuclear Envelope
Component Gene Protein(s) Expression Major Protein Function
Phenotype (Main Affected
Tissues)
Lamina LMNA LaminA,
LaminC
most differentiated
somatic cells
structural support of
nucleus; implicated in DNA
synthesis and transcription
(1) cardiomyopathy sometimes
with muscular dystrophy (cardiac
and skeletal muscle); (2) partial
lipodystrophy (adipose); (3) peripheral
neuropathy (peripheral nerve);
(4) progeroid features (early aging
affecting several tissues including
skin, adipose, arteries); and
(5) mandibuloacryl dysplasia (bone,
adipose, some progeroid features)
LMNB1 Lamin B1 all or most somatic
cells
as above leukodystophy (CNS glial cell)
LMNB2 Lamin B2 as above as above possible partial lipodystrophy
(adipose)
ZMPSTE24 ZMPSTE24 as above processing of prelamin A progeroid features and restrictive
dermopathy (skin and bone)
Nuclear membranes
and perinuclear
space
EDM Emerin as above binds lamins and other
proteins
cardiomyopathy with muscular
dystrophy (cardiac and skeletal
muscle)
LBR Lamin B
receptor
as above binds B-type lamins, DNA,
and heterochromatin
protein 1; sterol reductase
(1) Pelger-Hue¨t anomaly
(heterozygous; neutrophils) and
(2) Greenberg skeletal dysplasia
(homozygous; multi-systemic
developmental abnormalities most
prominently affecting bone that
causes neonatal lethality)
LEMD3 MAN1 as above binds rSmads, antagonizing
TGF-b signaling
sclerosing bone dysplasia (bone and
sometimes also skin)
SYNE1 Nesprin-1 as above component of LINC complex
that connects nucleus to
cytoplasmic cytoskeleton
cerebellar ataxia (CNS neurons)
TOR1A TorsinA as above AAA+ ATPase of ER and
perinuclear space; binds
lamina-associated
polypeptide 1
DYT1 dystonia (CNS neurons)
AAAS Aladin as above nuclear pore-associated triple-A syndrome (lower esophageal
sphinter, adrenal gland, lacrimal
gland)
Nuclear pore
complex
NUP155 Nup155 as above nucleocytoplasmic transport atrial fibrillation (heart)
NUP62 Nup62 as above nucleocytoplasmic transport infantile striatal necrosis (CNS)
RANBP2 RanBP2 as above nucleocytoplasmic transport acute necrotizing encephalopathy
(CNS)The Fascinating Case of LMNA
More than a dozen differently named clinical conditions (‘‘lami-
nopathies’’) have been linked to mutations in LMNA. These clin-
ical conditions can be grouped into phenotypes selectively
involving striated muscle, adipose tissue, peripheral nerve, or
multiple systems (Figure 3). Most inherited LMNA mutations
cause disorders that selectively affect striated muscle, with or
without tendon involvement. The laminopathies that involve stri-
ated muscle are almost all dominantly inherited and always
affect the heart, which appears clinically as a dilated cardiomy-
opathy with conduction system defects. Skeletal muscle
involvement is sometimes in a classical Emery-Dreifuss distribu-
tion (Figure 3) but can be variable or absent even for the same630 Developmental Cell 17, November 17, 2009 ª2009 Elsevier Incmutation, indicating the potential involvement of modifier genes.
The mutations that cause myopathy syndromes are mostly
missense or small in-frame deletions, which lead to expression
of variant proteins, or to splice site, truncation, or promoter
mutations that result in decreased levels of A-type lamins.
Loss-of-function of A-type lamins may underlie striated muscle
disease, as Lmna null mice develop abnormalities of cardiac
and skeletal muscle reminiscent of those seen in human subjects
(Sullivan et al., 1999). However, in humans, this loss of function
may result as a consequence of some type of ‘‘dominant interfer-
ence’’ mechanisms in the cases in which a variant lamin is ex-
pressed, as demonstrated by the development of severe heart
damage in transgenic mice overexpressing a lamin A variant.
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Tissue-Specific Phenotypes
Different LMNA mutations selectively affect stri-
atedmuscle, adipose, peripheral nerve, ormultiple
systems. The majority of autosomal dominant
mutations cause dilated cardiomyopathy with
variable skeletal muscle involvement. The diagram
shows the classical Emery-Dreifuss muscular
dystrophy scapulohumeral-peroneal distribution
of skeletal muscle involvement, in which there is
usually concurrent tendon contractures. However,
the same LMNAmutations can result in cardiomy-
opathy with minimal to no skeletal muscle disease
or involvement in a limb-girdle distribution. Other
autosomal dominant missense mutations in
LMNA, mostly those leading to a change in the
surface charge of the immunoglobulin fold in lam-
ins A and C, cause Dunnigan-type partial lipodys-
trophy, which has selective loss of subcutaneous
fat from the extremities, excessive fat accumula-
tion in the neck and face, and in most cases, the
subsequent development of insulin resistance
and diabetes mellitus. The autosomal recessive
R298C LMNA mutation causes a Charcot-Marie-Tooth type 2 peripheral neuropathy, characterized by a stocking-glove sensory neuropathy, an associated
pes cavus foot deformity, and additional variable features such as scoliosis. The de novo dominant LMNA G608G mutation causes the multisystem disease
HGPS, with progeroid features including growth retardation, micrognathia (small jaw), reduced subcutaneous fat, alopecia, osteoporosis, skin mottling, and
premature vascular occlusive disease. Other rare LMNA mutations also cause progeriod syndromes with some of the same features. The autosomal recessive
LMNA R527H mutation causes mandibuloacryl dysplasia, a disorder with a combination of progeroid features and partial lipodystrophy.that occurs in patients with Emery-Dreifuss muscular dystrophy
(Wang et al., 2006).
Dominantly inherited missense mutations, most frequently
those that change the surface charge of the immunoglobulin
fold in the tail domain of lamins A and C, cause Dunnigan-type
partial lipodystrophy, characterized by the selective loss of
peripheral subcutaneous fat around the time of puberty and, in
most cases, the subsequent development of insulin resistance
and diabetes mellitus (Cao and Hegele, 2000; Shackleton
et al., 2000; Speckman et al., 2000; Dhe-Paganon et al., 2002;
Krimm et al., 2002). Missense mutations that alter other regions
of A-type lamins may cause the same condition or slightly
different forms of partial lipodystrophy. Lmna null mice do not
develop lipodystrophy (Cutler et al., 2002), whereas overexpres-
sion of lamin A blocks adipocyte differentiation in vitro (Bogus-
lavsky et al., 2006), indicating that lipodystrophy-causing muta-
tions may act via a gain-of-function mechanism. Interestingly,
a recessively inherited missense mutation (R527H) in the immu-
noglobulin fold causes mandibuloacryl dysplasia, a disorder
characterized by partial lipodystrophy, progeroid features,
mandibular hypoplasia, and associated congenital bone abnor-
malities, further emphasizing the functional importance of this
LMNA domain (Novelli et al., 2002).
Alterations in A-type lamins also lead to a selective disorder of
peripheral nerve (De Sandre-Giovannoli et al., 2002). A reces-
sively inherited missense mutation (R298C) in the region of
LMNA encoding the rod domain of A-type lamins causes an
axonal neuropathy affecting peripheral nerves (classified as
Charcot-Marie-Tooth disease type 2B1). The sciatic nerves of
Lmna null mice show reduced axon density, axonal enlargement,
and the presence of unmyelinated axons (De Sandre-Giovannoli
et al., 2002), features similar to those seen in human patients and
consistent with the possibility that the R298C mutation may
impair some aspect of LMNA function.
Although there have been case reports of LMNA mutations
leading to various combinations of abnormalities between stri-ated muscle, fat, and peripheral nerve, for the most part, most
different LMNA mutations cause these different tissue-selective
disease phenotypes with minimal overlap. However, one group
of disorders caused by LMNAmutations, the progerias, is clearly
multisystemic. Hutchinson-Gilford progeria syndrome (HGPS) is
a rare but fascinating disorder that has long captured the imag-
ination of physicians and the lay public alike. Children with HGPS
appear normal at birth but by the first year of life show growth
retardation, micrognathia (small jaw), reduced subcutaneous
fat, alopecia, osteoporosis, and skin mottling. They subse-
quently develop premature vascular occlusive disease, with
most dying in the second decade from complications of coro-
nary artery or cerebrovascular disease. These features have
led to the notion that HGPS is a disorder of accelerated or
premature aging, but some tissues that are commonly affected
during physiological aging in later decades, such as the brain,
are not affected in children with this disorder.
Most cases of HGPS are caused by a dominant de novo point
mutation (G608G) that creates a novel splice donor site within
exon 11 of LMNA, causing an in-frame deletion of 150 base pairs
from this exon (Eriksson et al., 2003; De Sandre-Giovannoli et al.,
2003). Exons 11 and 12 of LMNA encode amino acids specific to
prelamin A, the precursor of lamin A, and not lamin C. Therefore,
the G608G HGPS-causing mutation causes an in-frame deletion
of 50 amino acids of near the carboxyl-terminus of prelamin A
that includes the ZMPSTE24 cleavage site (see discussion of
prelamin A processing in Nuclear Lamina section above). The
mutation therefore leads to the production of a truncated,
permanently farnesylated form of prelamin A, termed ‘‘progerin.’’
Several lines of evidence suggest strongly that accumulation
of farnesylated progerin contributes significantly to the progeroid
phenotype of HGPS. Zmpste24 null mice accumulate perma-
nently farnesylated prelamin A and exhibit a progeroid pheno-
type (Bergo et al., 2002; Penda´s et al., 2002). Similarly, loss-
of-function mutations in ZMPSTE24 cause a neonatal lethal
progeria-related syndrome in humans, termed restrictiveDevelopmental Cell 17, November 17, 2009 ª2009 Elsevier Inc. 631
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farnesylation partially ameliorates the progeroid phenotype in
both Zmpste24 null mice that accumulate farnesylated prelamin
A and LMNA knockin mice that express progerin (Fong et al.,
2006a; Yang et al., 2006). The progeroid phenotype of Zmpste24
null mice also depends on the gene dosage of prelamin A (Fong
et al., 2004). A study exploring the disease-causing features
of progerin demonstrated, however, that it has farnesylation-
dependent and farnesylation-independent toxicities (Yang
et al., 2008). These authors generated and compared two lines
of progerin-expressing mice, one of which had an additional
mutation preventing farnesylation. The mice expressing nonfar-
nesylated progerin still developed progeroid features, though
the phenotype was milder than that of the line expressing farne-
sylated progerin. Atypical progeriod disorders are also caused
by LMNA missense mutations that do not lead to accumulation
of progerin or farnesylated prelamin A, and mandibuloacryl
dysplasia, caused by the LMNA R527H mutation, has progeroid
features, further confounding our understanding of the patho-
genesis these enigmatic disorders.
Nuclear Envelope-Related Diseases That Are
Phenocopies of LMNA Myopathy
As described above, the first identified nuclear envelopathy
was X-linked Emery-Dreifuss muscular dystrophy, an identical
disease to that caused by some of the dominantly inherited
LMNA mutations discussed above. X-linked Emery-Dreifuss
muscular dystrophy is caused by mutations in the EDM gene en-
coding emerin (Bione et al., 1994), a single-pass transmembrane
protein that normally concentrates at the inner nuclearmembrane
by binding to lamin A via its nucleoplasmic domain.Most of these
are nonsense mutations that cause a loss of emerin from all cell
types. In fibroblasts from Lmna null mice, emerin redistributes
from the inner nuclear membrane to the endoplasmic reticulum,
and a similar effect is observed when A-type lamin variants that
causemyopathy are overexpressed in cultured cell lines (Sullivan
et al., 1999; O¨stlund et al., 2001; Raharjo et al., 2001). These data
suggest that the loss of inner nuclearmembrane-localizedemerin
function is an important event in most, if not all, causes of Emery-
Dreifuss muscular dystrophy. Limited data suggest that muta-
tions or polymorphisms in thegenesencoding lamina-associated
polypeptide 2 and nesprins, proteins that interact directly or indi-
rectly with A-type lamins, may also be associated with disease
phenotypes affecting striated muscle (Taylor et al., 2005; Zhang
et al., 2007). A-type lamins, nesprins, and possibly emerin are
components of the LINC complex that connects the nuclear
envelope to cytoskeletal networks (reviewed by Burke and
Roux, 2009) suggesting that the integrity of nucleocytoplasmic
connectionsmediatedby this complexmaybeparticularly impor-
tant in striated muscle cells.
CNS-Specific Nuclear Envelopathies
While the disorders caused by LMNAmutations spare the brain,
mutations in other genes encoding nuclear envelope proteins
cause diseases that selectively affect the CNS. Duplication of
the ubiquitously expressed LMNB1 gene that encodes lamin
B1 causes dominantly inherited adult-onset leukodystrophy,
a disease characterized by a selective yet widespread loss of
CNSmyelin (Padiath et al., 2006). In humans, LMNB1 duplication632 Developmental Cell 17, November 17, 2009 ª2009 Elsevier Inccauses approximately 1.5-fold increase in lamin B1 levels
(Padiath et al., 2006), and overexpression of lamin B1 leads to
the premature arrest of oligodendrocyte differentiation, alter-
ations in other nuclear envelope proteins and chromatin organi-
zation, and reduced transcription of myelin-related genes (Lin
and Fu, 2009).
Deletion mutations in SYNE1 encoding nesprin-1 cause
a recessively inherited cerebellar ataxia (Gros-Louis et al.,
2007). However, it is not clear if the disease-causing mutations
specifically affect nesprin-1 isoforms localized to the inner
nuclear membrane, the LINC complex or elsewhere. One report
so far suggests that, depending upon the nature of the mutation
in this gene with many exons and alternatively spliced RNAs,
more extensive, multi-systemic disease can result (Attali et al.,
2009). Another CNS selective nuclear envelopathy is DYT1 dys-
tonia, a developmental disorder of childhood characterized by
sustained abnormal involuntary movements that cause twisting
and turning of the involved body part. DYT1 dystonia is caused
by a dominantly inherited in-frame single amino acid deletion
the TOR1A gene that encodes the AAA-ATPase torsinA (Ozelius
et al., 1997). TorsinA is largely localized to the endoplasmic retic-
ulum peripheral to the nuclear envelope but the DYT1 mutation
causes it to concentrate abnormally in the perinuclear space of
the nuclear envelope (Gonzalez-Alegre and Paulson, 2004;
Goodchild and Dauer, 2004; Naismith et al., 2004). TorsinA defi-
cient or diseasemutation knock inmice are phenocopies of each
other: both exhibit morphological abnormalities of nuclear
membranes selectively in neurons (Goodchild et al., 2005).
These data suggest that neurons have a unique requirement
for nuclear envelope-localized torsinA function and suggest
that the DYT1 dystonia mutation impairs this activity. TorsinA
interacts with the nuclear envelope proteins lamina-associated
polypeptide-1 (Goodchild and Dauer, 2005) and nesprin-3
(Nery et al., 2008), possibly influencing the structure or function
of the LINC complex. The mechanisms underlying the CNS
specificity of nesprin-1-related cerebellar ataxia or DYT1 dysto-
nia are not understood.
Other Nuclear Envelopathies
Mutations in other widely expressed nuclear envelope proteins
also cause disorders that are relatively tissue specific. Polymor-
phisms or mutations in the gene LMNB2, which encodes lamin
B2, appear to predispose patients to develop an acquired lipo-
dystrophy (Hegele et al., 2006). Dominantly inherited mutations
in LBR, which encodes the lamin B receptor that binds to
B-type lamins and chromatin, cause Pelger-Hue¨t anomaly (Hoff-
mann et al., 2002). Pelger-Hue¨t anomaly is a clinically silent alter-
ation of nuclear shape in which the nuclei of blood neutrophils
are bilobed rather than the normal multilobular morphology.
Homozygous mutations in LBR lead to the perinatal lethal
syndrome Greenberg’s skeletal dysplasia. This syndrome
affects bone and several other organ systems and may be
related to loss of the sterol reductase activity of lamin B receptor
or to the absence of its lamin or chromatin binding features
(Waterham et al., 2003).
Nucleoporinopathies
Approximately 30 different proteins, including those known as
nucleoporins, comprise the nuclear pore complex, the sole site.
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Although pore complex proteins are assumed to be ubiquitously
expressed, recent data suggest that this is not always the case.
Moreover, as reviewed above, a growing body of literature is
implicating nuclear pore proteins in additional cellular functions,
most notably in mitosis. These new discoveries may in part
account for the varied group of diseases that result from muta-
tions in nuclear pore complex proteins. Achalasia-Addisonian-
ism-Alacrima syndrome, also known as triple-A syndrome, is
a recessively inherited disorder characterized by adrenal insuffi-
ciency, dysfunction of the lower esophageal sphincter that inter-
fers with normal swallowing (achalasia), and dry eyes (alacrima).
Triple-A syndrome is caused by loss-of-function mutations in the
AAAS gene that encodes a WD-repeat protein called aladin (Tul-
lio-Pelet et al., 2000). Aladin is a component of the nuclear pore
complex, but the triple-A mutation prevents pore localization
(Cronshaw et al., 2002; Cronshaw andMatunis, 2003). However,
no studies have determined whether themislocalization of aladin
causes abnormal nuclear pore transport or whether, similar to
other pore proteins, aladin has functions distinct from its role
at the nuclear pore.
More recently, a recessively inherited missense mutation in
the nucleoporin gene NUP155 was found to cosegregate with
atrial fibrillation, which causes sudden death; heterozygous
null Nup155 mice also develop atrial arrhythmias (Zhang et al.,
2008). Loss of NUP155 function appears to disrupt nuclear
pore function (Zhang et al., 2008), and in contrast tomost nuclear
envelopathies, the relatively increased expression of NUP155 in
the heart appears to at least partly explain the preferential
involvement of cardiac tissue. Lastly, two other nucleoporinopa-
thies manifest as clinically related CNS disorders. A recessively
inherited missense mutation in the nucleoporin gene NUP62
causes infantile bilateral striatal necrosis (Basel-Vanagaite
et al., 2006), whereas a dominantly inherited missense mutation
inRanBP2, encoding another nucleoporin, leads to susceptibility
to infection-triggered acute necrotizing encephalopathy (Neilson
et al., 2009). While these are distinct disorders, they both feature
the acute development of bilateral necrotic lesions of deep brain
structures. It is also interesting that acute necrotizing encepha-
lopathy is triggered by viral or other infections, given that
Nup96+/ mice also have defects in innate and adaptive immu-
nity (Faria et al., 2006). These intriguing reports suggest that
nuclear pore complex composition may not be invariant during
development and in different tissues and that certain proteins
have tissue-specific roles, possibly in mediating nucleocyoplas-
mic transport of particular cargoes.
Beyond the Barrier Function of the Nuclear Envelope
The data from model organisms and human subjects with
Mendelian diseases convincingly demonstrate that the nuclear
envelope functions as much more than a simple barrier sepa-
rating the nuclear and cytoplasmic compartments. This has led
to the hypothesis that, in addition to its barrier function, the
nuclear envelope is a node that integrates important signals in
developing and mature tissue and that the disruption of
nuclear-envelope-localized signaling contributes to a diverse
array of human diseases, perhaps even normal aging. These
‘‘signaling’’ functions are likely to be diverse, ranging from the
regulation of ‘‘classical’’ signal transduction pathways, to inte-gration of cellular mechanical events and to the control of the
nucleocytoplasmic transport of specialized cargoes.
Studies of the inner nuclear membrane protein MAN1 illustrate
how the nuclear envelope can participate in the regulation of
a classical signaling pathway. MAN1 has an amino-terminal
nucleoplasmic domain, two transmembrane segments, and
a nucleoplasmic carboxyl-terminal domain. The carboxyl-
terminal domain of mammalian MAN1 binds to rSmads, antago-
nizing cellular responses to transforming growth factor-b and
bone morphogenic protein (Hellemans et al., 2004; Lin et al.,
2005; Pan et al., 2005). Inhibition of transforming growth
factor-b signaling by MAN1 has been confirmed in knockout
mice deficient for the protein (Ishimura et al., 2006; Cohen
et al., 2007). Consistent with these findings, human subjects
with heterozygous loss of functionmutation in the gene encoding
MAN1 exhibit bone and skin abnormalities, potentially because
of enhanced sensitivity of these tissues to transforming growth
factor-b or bone morphogenic protein (Hellemans et al., 2004).
Transforming growth factor-b superfamily signaling is regulated
at multiple steps, and the fact that selective abnormalities of
bone and skin result from the loss of MAN1 function indicates
that it is a particularly relevant negative regulator of signaling in
these tissues during postembryonic life. Evidence suggests
that A-type lamins may also play a role in controlling transform-
ing growth factor-b signaling by affecting the activities of down-
stream nuclear phosphatases (van Berlo et al., 2005). Redundant
steps in the regulation of signal transduction pathways that are
variable in different cell types could potentially explain tissue-
selective phenotypes in other diseases associated with nuclear
envelope alterations.
Abnormalities in A-type lamins have been shown to impact on
the activities of other signal transduction pathways. Expression
of progerin, the truncated prelamin A in HGPS, activates Notch
signaling, promoting the differentiation of mesenchymal stem
cells down an osteogenic as opposed to an adipogenic fate
(Scaffidi and Misteli, 2008). Similarly, Zmpste24/ mice that
accumulate unprocessed, farnesylated prelamin A exhibit
abnormalities in the proliferative capacity of epidermal stem cells
and altered signaling, including that through the Wnt pathway
(Espada et al., 2008). A-type lamins bind to retinoblastoma
protein (Mancini et al., 1994; Ozaki et al., 1994), likely in complex
with the nucleoplasmic protein lamina-associated polypeptide-
2a (Pekovic et al., 2007). In cells lacking A-type lamins, lamina-
associated polypeptide-2a is mislocalized within nuclear aggre-
gates and this occurs concurrently with cell cycle arrest and
accumulation of retinoblastoma protein within nuclear speckles
(Pekovic et al., 2007). Loss of emerin also disrupts retinoblas-
toma protein/E2F and MyoD pathways during muscle regenera-
tion (Melcon et al., 2006). These signaling pathways play critical
roles in controlling proliferation, fate determination and other
aspects of stem cell biology, demonstrating a possible function
of the nuclear lamina in cell differentiation during development
as well as the maintenance of somatic tissues.
Apart from these ‘‘classical’’ signal transduction pathways,
several lines of evidence suggest that the nuclear envelope plays
an important role in the modulation of mechanical stress-
induced signaling pathways. Fibroblasts from mice lacking
A-type lamins exhibit altered nuclear morphology and defective
nuclear mechanics and abnormally activate transcriptionalDevelopmental Cell 17, November 17, 2009 ª2009 Elsevier Inc. 633
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2004), and similar abnormalities are present in cells from human
subjects with HGPS that express progerin (Verstraeten et al.,
2008). Abnormalities of stress-related signaling have also been
observed in cardiac tissue from Lmna knockin mice that carry
an Emery-Dreifuss muscular dystrophy missense mutation
(Muchir et al., 2007). In cardiac cells, mechanical stress activates
the ERK and JNK branches of the MAP kinase pathway. In
LmnaH222P/H222P mice, these pathways appear to be abnormally
activated in heart and, to a lesser extent, skeletal muscle, sug-
gesting that only cells continually exposed to mechanical strain
have abnormal activation. Long-term superactivation of ERK
andJNKaredetrimental to normal heart functioningandsystemic
treatmentwith an inhibitor of ERKsignalingprevents or delays the
onset of cardiomyopathy in LmnaH222P/H222P mice (Muchir et al.,
2009), potentially linking these aberrant signaling events to a clin-
ically relevant disease phenotype. Defects in protein interactions
leading to mechanical instability could directly contribute to
cellular damage, independent of resultant alterations in signaling
pathways, particularly in cells under constant mechanical stress,
such as myocytes. Nonetheless, these data illustrate how an
underlying abnormality of nuclear envelope structure or function
can be amplified by the unique features of a particular cell type,
a scenario thatmaycontribute to the tissue-selective phenotypes
characteristic of nuclear envelopathies.
One can imagine similarly variable responses to other
stressors, such as the complex, coordinated events that occur
between the nucleus and cytoskeleton during major cell migra-
tory events that take place during embryonic development. As
noted above and reviewed elsewhere in this issue by Burke,
the nucleus is connected to cytoskeletal elements via the LINC
complex. The LINC complex appears to play a critical role in
nuclear positioning and movement, events that are critical for
proper cell migration. Indeed, fibroblasts lacking nesprin-2-giant
or A-type lamins have abnormal nuclear movement and cell
migration (Lee et al., 2007; Lu¨ke et al., 2008). Well-coordinated
nuclear movements appear particularly important during CNS
development, where they are important in both neurogenesis
and neuronal migration. For example, as neural precursor cells
migrate into developing neocortex, centrosomes move continu-
ously and in advance of nuclei, which follow by leaps rather than
by smooth, gradual transitions (Tsai et al., 2007). Disruption of
the nuclear envelope or variations in connections to cytoskeletal
elements, either via the LINC complex or other attachments,
could disrupt these processes, causing relatively selective
effects on cell types that heavily utilize these processes. Fibro-
blasts lacking torsinA, the protein affected in the CNS selective
nuclear envelopathy, also exhibit abnormalities in nuclear move-
ment and cell migration (Nery et al., 2008), raising the possibility
that abnormalities of neuronal migration could contribute to the
pathogenesis of this neurodevelopmental disorder.
The nuclear pore complex itself, which controls signaling
between the cytosol and nucleus through its classical transport
function, has similarly emerged as a highly complex machine
that modulates many aspects of cellular behavior through
a range of increasingly understood nonclassical functions. The
pore complex is intimately involved in the regulation of gene
action by controlling the passage of transcription factors in and
mRNA out of the nucleus. As the lamina is associated with634 Developmental Cell 17, November 17, 2009 ª2009 Elsevier Incnuclear pore complexes (Gerace et al., 1978), alterations in the
lamins or associated integral inner nuclear membrane proteins
may affect specific nuclear pore-related processes. The lamin-
binding inner nuclear membrane protein emerin, which is not ex-
pressed in most cases of X-linked Emery-Dreifuss muscular
dystrophy, appears to stimulate the export of b-catenin, and
loss of emerin leads to increased nuclear accumulation of this
transcription coactivator (Markiewicz et al., 2006). There is also
increasing evidence to suggest that the ‘‘FG repeat’’ motif found
in multiple nucleoporins can function as direct transcriptional
activators, even at intranuclear sites distant from the nuclear
pore (Wang et al., 2007). Nucleoporins have also been localized
to the kinetochore and atmicrotubules and have been implicated
as attachment sites for nucleocytoskeletal connections (Zuccolo
et al., 2007). These varied functions likely contribute to the unex-
pected diversity of phenotypes that result from mutations in
nuclear pore components, both in model organisms and human
disease.
Future Perspectives and Directions
Apart from the great progress made in understanding nucleocy-
toplasmic transport through the nuclear pore, it has been
tremendously challenging to identify and dissect the specific
biological processes that occur at the nuclear envelope. Indeed,
a relatively complete accounting of the mammalian inner nuclear
membrane proteome has only fairly recently been obtained in
only one tissue, and the state of knowledge of nuclear enve-
lope-linked functions is exemplified by the ‘‘Nuclear Envelope
Transmembrane (NET)’’ nomenclature used to identify these
proteins (Schirmer et al., 2003). Nevertheless, the continuing
characterization of nuclear envelope proteins, for example, the
nesprins, is leading to important new insights into nuclear enve-
lope organization and function. Importantly, recent years have
witnessed tremendous advances in linking human disease to
mutations in genes encoding nuclear envelope proteins. These
discoveries, which may be viewed as ‘‘nature’s experiments,’’
are valuable because they connect (often surprisingly) whole
organism phenotypes to nuclear envelope proteins and, thus,
form the basis for future mechanistic studies aimed at linking
these proteins to biological functions.
Some of the striking tissue selectivity observed in human
nuclear envelopathies and related model organisms may simply
be due to differences in the developmental expression patterns
in different cell and tissues types. However, only a few small
studies have characterized the developmental expression
patterns of individual nuclear envelope proteins in various cells
and tissues, the most comprehensive being an analysis of the
onset of A-type lamin expression during early mouse develop-
ment (Ro¨ber et al., 1989). A comprehensive and systemic anal-
ysis of the nuclear envelope proteome in different mammalian
tissues at different developmental stages is clearly needed.
This information would likely provide insight into some of the
striking phenotypes that result from altering the function of
nuclear envelope proteins and would be a valuable resource
for the research community. A similar analysis, performed in
human tissues from patients with nuclear envelopathies or
mouse models of these diseases, would enable investigators
to correlate disease and developmental phenotypes with alter-
ations in protein expression patterns..
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tions of nuclear envelope proteins in different vertebrate tissues
is the fact that many of these proteins have essential functions
during embryogenesis, leading to the frequent occurrence of
embryonic lethality in mouse mutants. For example, Lemd3
null mice that do not express MAN1 die at embryonic day 10.5
secondary to abnormal yolk sac vasculogenesis, preventing
the study of this protein inmature bone. This issue is of consider-
able interest because of occurrence of sclerosing bone dyspla-
sias in patients with dominantly inherited mutations in the
homologous gene in humans. Thus, the generation and charac-
terization of mice with conditional loss-of-function alleles for
nuclear envelope proteins is needed to explore the role of these
proteins in mature tissues. Importantly, the European Condi-
tional Mouse Mutagenesis Project (EUCOMM; http://www.
eucomm.org/) is currently generating a number of such mice,
which are freely available to academic researchers.
Considerable attention has been given to the abnormal gross
nuclear envelope architecture that occurs in cells with muta-
tions in genes encoding nuclear envelope proteins and from
subjects with ‘‘laminopathies.’’ Indeed, altered nuclear mor-
phology has been considered a virtually defining feature of lam-
inopathies. The abnormal nuclear morphology, which includes
‘‘blebbing’’ and increased lobulation of the nuclear envelope,
appears to be related to disease pathogenesis, as interventions
that ameliorate physiological phenotypes in mice also affect the
reversal of nuclear shape alterations in cultured cells. For
example, administration of a farnesyltransferase inhibitor to
a mouse model of HGPS improves body weight curves,
reduces bone abnormalities, and also reverses the abnormali-
ties in nuclear morphology in fibroblasts cultured from these
animals (Yang et al., 2005, 2006). However, such correlations
do not resolve whether the observed abnormal nuclear enve-
lope abnormalities are actually responsible for a specific cellular
phenotype or whether this is a correlation without causation.
Future studies must go beyond correlating abnormalities in
nuclear envelope morphology with phenotypes. They must
instead attempt to explain whether and how altered nuclear
morphology contributes to pathogenic mechanisms, such as
abnormal signal transduction, nucleocytoplasmic transport, or
cell stability. In particular, the potential effects of altered nuclear
structure on nucleocytoplasmic transport have received little
attention to date. Studies that link the effects of altered nuclear
morphology to pathogenic mechanisms will be of value far
beyond the relatively rare inherited nuclear envelopathies, as
the disruption of nuclear envelope morphology is also impli-
cated as an important pathogenic events in cancer as well as
aging. Thus, structure-function of the nuclear envelope are
likely to yield a number of insights that are both fundamentally
important to the study of both cell physiology and human
disease.
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